Form S-4 - Registration of securities, business combinations:
SEC Accession No. 0001213900-24-042529
Filing Date
2024-05-14
Accepted
2024-05-13 21:11:37
Documents
101

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0205122-01.htm   iXBRL S-4 11187490
2 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ORUKA THERAPEUTICS, INC ea020512201ex3-5_arcabio.htm EX-3.5 129870
3 BYLAWS OF ORUKA THERAPEUTICS, INC, AS CURRENTLY IN EFFECT ea020512201ex3-6_arcabio.htm EX-3.6 102170
4 INVESTOR RIGHTS AGREEMENT, DATED MARCH 6, 2024, BY AND AMONG ORUKA THERAPEUTICS, ea020512201ex4-3_arcabio.htm EX-4.3 146682
5 ORUKA THERAPEUTICS, INC. 2024 EQUITY INCENTIVE PLAN ea020512201ex10-40_arcabio.htm EX-10.40 95535
6 FORM OF RESTRICTED STOCK NOTICE AND RESTRICTED STOCK PURCHASE AGREEMENT OF ORUKA ea020512201ex10-41_arcabio.htm EX-10.41 90208
7 FORM OF STOCK OPTION AGREEMENT UNDER ORUKA THERAPEUTICS, INC. 2024 EQUITY INCENT ea020512201ex10-42_arcabio.htm EX-10.42 80436
8 AMENDED AND RESTATED DIRECTOR OFFER LETTER, DATED MARCH 22, 2024, BETWEEN ORUKA ea020512201ex10-43_arcabio.htm EX-10.43 15782
9 DIRECTOR OFFER LETTER, DATED APRIL 24, 2024, BETWEEN ORUKA THERAPEUTICS, INC. AN ea020512201ex10-44_arcabio.htm EX-10.44 10924
10 FORM OF INDEMNIFICATION AGREEMENT BETWEEN ORUKA THERAPEUTICS, INC. AND ITS DIREC ea020512201ex10-45_arcabio.htm EX-10.45 81171
11 AMENDED AND RESTATED EMPLOYMENT OFFER LETTER, DATED FEBRUARY 14, 2024, BY AND BE ea020512201ex10-46_arcabio.htm EX-10.46 64750
12 AMENDED AND RESTATED EMPLOYMENT OFFER LETTER, DATED MARCH 11, 2024, BY AND BETWE ea020512201ex10-47_arcabio.htm EX-10.47 69104
13 AMENDED AND RESTATED EMPLOYMENT OFFER LETTER, DATED MARCH 15, 2024, BY AND BETWE ea020512201ex10-48_arcabio.htm EX-10.48 61203
14 AMENDED AND RESTATED EMPLOYMENT OFFER LETTER, DATED APRIL 12, 2024, BY AND BETWE ea020512201ex10-49_arcabio.htm EX-10.49 54221
15 LIST OF SUBSIDIARIES OF ARCA BIOPHARMA, INC ea020512201ex21-1_arcabio.htm EX-21.1 3733
16 CONSENT OF KPMG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF ARCA BIOPH ea020512201ex23-1_arcabio.htm EX-23.1 1774
17 CONSENT OF PRICEWATERHOUSECOOPERS LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING ea020512201ex23-2_arcabio.htm EX-23.2 1546
18 CONSENT OF LUCID CAPITAL MARKETS, LLC ea020512201ex99-5_arcabio.htm EX-99.5 5234
19 CONSENT OF LAWRENCE KLEIN TO SERVE AS A DIRECTOR OF ARCA BIOPHARMA, INC., TO BE ea020512201ex99-6_arcabio.htm EX-99.6 2452
20 CONSENT OF KRISTINE BALL TO SERVE AS A DIRECTOR OF ARCA BIOPHARMA, INC., TO BE R ea020512201ex99-7_arcabio.htm EX-99.7 2435
21 CONSENT OF CARL DAMBKOWSKI TO SERVE AS A DIRECTOR OF ARCA BIOPHARMA, INC., TO BE ea020512201ex99-8_arcabio.htm EX-99.8 2441
22 CONSENT OF PETER HARWIN TO SERVE AS A DIRECTOR OF ARCA BIOPHARMA, INC., TO BE RE ea020512201ex99-9_arcabio.htm EX-99.9 2398
23 CONSENT OF SAMARTH KULKARNI TO SERVE AS A DIRECTOR OF ARCA BIOPHARMA, INC., TO B ea020512201ex99-10_arcabio.htm EX-99.10 2406
24 CONSENT OF CAMERON TURTLE TO SERVE AS A DIRECTOR OF ARCA BIOPHARMA, INC., TO BE ea020512201ex99-11_arcabio.htm EX-99.11 2400
25 FILING FEE TABLE ea020512201ex-fee_arcabio.htm EX-FILING FEES 22092
26 GRAPHIC tarca_001.jpg GRAPHIC 61255
27 GRAPHIC timage_001.jpg GRAPHIC 552437
28 GRAPHIC timage_002.jpg GRAPHIC 913184
29 GRAPHIC timage_003.jpg GRAPHIC 237818
30 GRAPHIC timage_004.jpg GRAPHIC 319835
31 GRAPHIC timage_005.jpg GRAPHIC 121237
32 GRAPHIC timage_006.jpg GRAPHIC 315435
33 GRAPHIC timage_007.jpg GRAPHIC 321935
34 GRAPHIC tlucid_sig.jpg GRAPHIC 29511
35 GRAPHIC toruka_logo.jpg GRAPHIC 97711
36 GRAPHIC ex10-43_001.jpg GRAPHIC 3410
37 GRAPHIC ex10-44_001.jpg GRAPHIC 3326
38 GRAPHIC ex10-48_001.jpg GRAPHIC 3017
39 GRAPHIC ex10-49_001.jpg GRAPHIC 3016
40 GRAPHIC ex23-1_001.jpg GRAPHIC 3683
  Complete submission text file 0001213900-24-042529.txt   26983994

Data Files

Seq Description Document Type Size
41 XBRL SCHEMA FILE abio-20240331.xsd EX-101.SCH 46299
42 XBRL CALCULATION FILE abio-20240331_cal.xml EX-101.CAL 31860
43 XBRL DEFINITION FILE abio-20240331_def.xml EX-101.DEF 252559
44 XBRL LABEL FILE abio-20240331_lab.xml EX-101.LAB 455056
45 XBRL PRESENTATION FILE abio-20240331_pre.xml EX-101.PRE 261234
105 EXTRACTED XBRL INSTANCE DOCUMENT ea0205122-01_htm.xml XML 1617419
Mailing Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021
Business Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021 7209402200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-4 | Act: 33 | File No.: 333-279387 | Film No.: 24941169
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)